1. Effects of Levocarnitine on Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients: A Randomized Controlled Trial
- Author
-
Terumi Higuchi, Masanori Abe, Toshio Yamazaki, Mari Mizuno, Erina Okawa, Hideyuki Ando, Osamu Oikawa, Kazuyoshi Okada, Fumito Kikuchi, and Masayoshi Soma
- Subjects
atherosclerosis ,brachial-ankle pulse wave velocity ,carnitine ,end-stage kidney disease ,hemodialysis ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Background and Aims: Atherosclerotic cardiovascular disease is the most common cause of mortality in patients with end-stage kidney disease. Chronic kidney disease patients often exhibit a deficiency in l-carnitine due to loss during hemodialysis (HD). We studied the effects of l-carnitine supplementation on brachial-ankle pulse wave velocity (baPWV), a marker of atherosclerosis, in HD patients. Methods: This was a prospective, open-label, randomized, parallel controlled, multi-center trial testing the anti-atherosclerotic efficacy of oral l-carnitine administration (20 mg/kg/day). HD patients (n = 176, mean age, 67.2 ± 10.3 years old; mean duration of HD, 54 ± 51 months) with plasma free l-carnitine deficiency (
- Published
- 2014
- Full Text
- View/download PDF